Holding(s) in Company
Genesis Emerging Markets Fund Ld
For filings with the FSA include the annex | Â | ||||||||||
For filings with issuer exclude the annex | |||||||||||
 | |||||||||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||||||||
 |  |  | |||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Genesis Emerging Markets | ||||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||||||||
An acquisition or disposal of voting rights | Â | X | |||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | Â | ||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | Â | ||||||||||
An event changing the breakdown of voting rights | Â | ||||||||||
Other (please specify): | Â | Â | Â | ||||||||
3. Full name of person(s) subject to the notification obligation: iii |
 | SARASIN & PARTNERS LLP | |||||||||
4. Full name of shareholder(s) (if different from 3.):iv |
BNP Paribas Security Services (Jersey)
RBC Dexia Investor Services Bank (Luxembourg) RBC Dexia Investor Services Bank (Zurich) Bank Sarasin & Co Ltd (Zurich) The Bank of New York Mellon (Brussels(Pooled)) The Bank of New York Mellon (Brussels) |
||||||||||
5. Date of the transaction and date on which the threshold is crossed or reached: v |
26.07.2012 | ||||||||||
6. Date on which issuer notified: | 27.07.2012 | ||||||||||
7. Threshold(s) that is/are crossed or reached: vi, vii |
5% |
8. Notified details: | |||||||||||||||||||||||||||||||||
A: Voting rights attached to shares viii, ix | |||||||||||||||||||||||||||||||||
Class/type of shares
|
 |
Situation previous to the triggering transaction |
 | Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||
Number of Shares |
 |
Number of Voting Rights |
Number of shares |
 |
Number of voting rights |
 | % of voting rights x | ||||||||||||||||||||||||||
Direct | Direct xi | Â | Indirect xii | Direct | Â | Indirect | |||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||
GG00B4L0PD47 | 7,158,821 | 7,158,821 | 5,908,821 | Â | 5,908,821 | Â | 4.3781% | ||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||
B: Qualifying Financial Instruments | |||||||||||||||||||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||||||
Type of financial instrument |
 |
Expiration date xiii |
 |
Exercise/ Conversion Period xiv |
 |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
 |
% of voting rights |
|||||||||||||||||||||||||
 |  |  |  |  | |||||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||||||||||||||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||||||
Type of financial instrument |
 | Exercise price | Expiration date xvii |  |
Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | Â | % of voting rights xix, xx | |||||||||||||||||||||||||
 |  |  |  |
 |
Nominal | Â | Delta | ||||||||||||||||||||||||||
 |  | ||||||||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||
Total (A+B+C) | |||||||||||||||||||||||||||||||||
Number of voting rights | Â | Percentage of voting rights | |||||||||||||||||||||||||||||||
5908821 | 4.3781% |
9. Chain of controlled undertakings through which the voting
rights and/or the financial instruments are effectively held, if applicable: xxi |
||||
 |
||||
 | ||||
Proxy Voting: | ||||
10. Name of the proxy holder: | Â | |||
11. Number of voting rights proxy holder will cease to hold: |
 | |||
12. Date on which proxy holder will cease to hold voting rights: |
 | |||
 | ||||
13. Additional information: |
 |  | ||
14. Contact name: | Julian Connelly | |||
15. Contact telephone number: | +44 (0) 20 7038 7255 |